Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000930550 | SCV001076204 | likely benign | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000930550 | SCV001788532 | likely benign | not provided | 2020-04-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268358 | SCV002551614 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390942 | SCV002698108 | likely benign | Hereditary cancer-predisposing syndrome | 2020-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |